MP03: Bladder Cancer: Invasive I

Poster Session Moderator(s)

• 

  Sherri Donat, MD, FACS

  MSKCC, NY Weill Cornell Medical College
• 

  Stanley Malkowicz, MD

  University of Pennsylvania
• YL

  Young-Goo Lee, MD

  Hallym University

Presentations:

• 7:00 AM – 8:15 AM

  MP03-01: Robot-Assisted Radical Cystectomy with Extracorporeal Urinary Diversion does not Increase Ureteroenteric Stricture Rate: Outcomes from a Randomized Trial comparing Open versus Robotic Cystectomy
  

  Poster Presenter: Benjamin Beech, MD, FRCSC
• 7:00 AM – 8:15 AM

  MP03-02: Association Between Visibly Complete Transurethral Resection of Bladder Tumor and Pathologic Downstaging Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer
  

  Poster Presenter: Bryce Alden Baird, MD
• 7:00 AM – 8:15 AM

  MP03-03: Targeting V1/Chase to overcome Gemcitabine Resistance
  

  Poster Presenter: Semih Sarcan, MD
• 7:00 AM – 8:15 AM

  MP03-04: Analysis of Complications after Robot-Assisted Radical Cystectomy between 2005-2020: Results from the International Robotic Cystectomy Consortium
  

  Poster Presenter: Yousuf Omar Ramahi, BS
• 7:00 AM – 8:15 AM

  MP03-05: How does the type of urinary diversion affect health related quality of life (HRQOL) in the course of four years after radical cystectomy? - A propensity score-matched analysis
  

  Poster Presenter: Lennert Eismann, MD – Department of Urology, LMU
• 7:00 AM – 8:15 AM

  MP03-06: Prospective study on FDG-PET/CT for On-treatment Assessment of Response to Neoadjuvant or Induction Chemotherapy in Invasive Bladder Cancer
  

  Poster Presenter: Sarah Einerhand
• 7:00 AM – 8:15 AM

  MP03-07: Impact of prior intravesical bacillus Calmette-Guerin therapy for non-muscle invasive bladder cancer on the efficacy of pembrolizumab in patients with metastatic urothelial carcinoma
  

  Poster Presenter: Rikiya Taoka, MD, PHD – Kagawa University
• 7:00 AM – 8:15 AM

  MP03-08: Association between ureteral clamping time and acute kidney injury during robot-assisted radical cystectomy
  

  Poster Presenter: Yudai Ishiyama, MD
• 7:00 AM – 8:15 AM

  MP03-09: Impact of variant histology and immunohistochemistry on response to adjuvant chemotherapy in urothelial muscle-invasive bladder cancer
  

  Poster Presenter: Florestan Koll
• 7:00 AM – 8:15 AM

  MP03-10: Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity
  

  Poster Presenter: Francesco Chierigo
• 7:00 AM – 8:15 AM

  MP03-11: High Expression of AHNAK2 is Associated with Biologically Aggressive Findings and Poor Survival in Patients Treated with Radical Cystectomy
  

  Poster Presenter: Dai Koguchi – Kitasato University Hospital
• 7:00 AM – 8:15 AM

  MP03-12: Association of use of potassium competitive acid blockers and effectiveness of pembrolizumab in patients with metastatic urothelial carcinoma
  

  Poster Presenter: Wataru Fukuokaya, MD – The Jikei University School of Medicine
• 7:00 AM – 8:15 AM

  MP03-13: Identification of Muscle-Invasion Status in Bladder Cancer Patients Using Natural Language Processing and Machine Learning
  

  Poster Presenter: Ruixin Yang
• 7:00 AM – 8:15 AM

  MP03-14: Neoadjuvant versus adjuvant chemotherapy in bladder cancer: A nationwide cohort study
  

  Poster Presenter: Shim Jaehun, MD – Chungang Hospital
• 7:00 AM – 8:15 AM

  MP03-15: Primary versus Secondary Muscle Invasive Bladder Cancer: Comparing the Pathologic and Oncologic Outcomes between Both forms of Muscle Invasive Disease When Treated with Standard of Care.
  

  Poster Presenter: Tarik Benidir, MD, FRCS, MSc
• 7:00 AM – 8:15 AM

  MP03-16: Feasibility, Usability and Utility of a Remote Symptom Assessment Tool After Radical Cystectomy
  

  Poster Presenter: Heather L. Huelster, MD – Moffitt Cancer Center
• 7:00 AM – 8:15 AM

  MP03-17: Patient, Physician, Hospital Factors Associated With Readmission After Radical Cystectomy
  

  Poster Presenter: Kassem Faraj, MD
• 7:00 AM – 8:15 AM

  MP03-18: Chronological transition in outcome of second-line treatment in patients with metastatic urothelial cancer after pembrolizumab usage: A multicenter analysis
  

  Poster Presenter: Teruki Isobe, MD,DO – Nagoya City University
• 7:00 AM – 8:15 AM

  MP03-19: Association between immune-related Adverse Events and Survival of Patients with metastatic Urothelial Carcinoma Treated with Pembrolizumab
  

  Poster Presenter: Kazutaka Nakamura, MD – Tokiwakai Jyoban Hospital
• 7:00 AM – 8:15 AM

  MP03-20: Contemporary Analysis of Cystectomy Complications
  

  Poster Presenter: Kevin Chua, MD – Rutgers Robert Wood Johnson